There are several glucagon-like peptide-1 (GLP-1) medications besides semaglutide, including: Liraglutide ( Saxenda , Victoza) Dulaglutide ( Trulicity ) There are also other medications that treat obesity, type 2 diabetes, and cardiovascular disease
Malondialdehyde was evaluated as an indicator of lipid peroxidation
Mariza Snyder, functional practitioner, hormone expert, and author of The Perimenopause Revolution to unpack the often-misunderstood phase of perimenopause
Redness, itching, or swelling at the injection site occurs with both peptides but is typically mild and self-resolving
A longitudinal and retrospective study on elderly patients with type 2 diabetes reported that long-term use of semaglupeptide was associated with decreased grip strength and accelerated sarcopenia, raising concerns that GLP-1RAs may have adverse effects on neuromuscular health [54]